reports
- Roy Chen Chengzhi
Singapore Airlines (SIA SP) - FY24: Results In Line; Expect Moderating...
SIA’s FY24 headline net profit of S$2.67b (+24% yoy) was in line with our expectations at 101% of our forecast. FY24’s final DPS of 38 S cents was slightly above our projection. We expect SIA’s earnings to go downhill in the next two years, driven by pax and cargo yield moderation as competition catches up, but still meaningfully above pre-pandemic levels with SIA’s strengthened market leading position. Maintain HOLD on SIA, with a slightly higher target price of S$6.35, based on 1.18x FY25F P/B...
- Leonard Law
Lucror Analytics - Morning Views Asia
Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar. To request full and unrestricted access to Lucror’s research and analytics platform, please visit
- Stevanus Juanda
Consumer – Consumer Companies Benefit From Margin Expansion; Retail Co...
Consumer companies recorded an average NPAT growth of 14.8% in 1Q24 and retailers recorded an average growth of 151.1% yoy. A recurring theme among consumer companies is that a decline in raw material prices caused margin expansion and profit growth. Retail companies saw triple-digit growth as Lebaran fell in 1Q24 compared to 2Q last year. Maintain OVERWEIGHT. Our picks: ACES and CMRY.
- Roy Chen Chengzhi
- Maskun Ramli
- Stevanus Juanda
- Lynn Song
- Min Joo Kang
- Nicky Mapa
- Rob Carnell
- James Ratzer
Moody's Ratings assigns ratings to four classes of notes issued by Cer...
Moody's Ratings (Moody's) has assigned ratings to four classes of notes issued by Cerberus Loan Funding XLVI, L.P. (the "Issuer" or "Cerberus XLVI"). Moody's rating action is as follows: U.S.$216,000,000 Class A Senior Secured Floating Rate Notes due 2036, Definitive Rating Assigned Aaa (sf) U....
Erasca Announces Strategic In-Licensing of RAS-Targeting Franchise
Erasca Announces Strategic In-Licensing of RAS-Targeting Franchise Pan-RAS molecular glue ERAS-0015 and pan-KRAS inhibitor ERAS-4001 are potent, oral inhibitors with potential best-in-class profiles in RASm solid tumors Pipeline prioritization and workforce restructuring sharpens focus on programs targeting the highest unmet needs and with highest probability of success Priced concurrent $160 million equity offering Erasca to host conference call and webcast Friday, May 17, 2024 at 8:30 am ET SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-...
HUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematolog...
HUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematological Malignancy Programs Data to be Presented at the upcoming EHA2024 Congress HONG KONG, SHANGHAI and FLORHAM PARK, N.J., May 17, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“”) (Nasdaq/AIM:HCM; HKEX:13) today announces that topline and subgroup results from the ESLIM-01 Phase III study of sovleplenib, as well as new and updated data related to novel investigational hematological malignancy therapies HMPL-306, HMPL-760 and tazemetostat, will be presented at the upcoming European Hematology Association (“EHA”) Hy...
Erasca Announces Pricing of Underwritten Offering of Common Stock
Erasca Announces Pricing of Underwritten Offering of Common Stock SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced the pricing of an underwritten offering of 86,486,486 shares of its common stock at a price of $1.85 per share. All of the shares to be sold in the offering are to be sold by Erasca. The gross proceeds to Erasca from the offering, before deducting the underwriting dis...
ThreeD Capital Inc. Issues Early Warning Report in Connection With The...
ThreeD Capital Inc. Issues Early Warning Report in Connection With The Disposition of Securities of infinitii ai inc. TORONTO, May 16, 2024 (GLOBE NEWSWIRE) -- ThreeD Capital Inc. (“ThreeD”) (CSE:IDK / OTCQX:IDKFF) a Canadian based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, announces that through a series of recent transactions (“Dispositions”), ThreeD disposed of ownership and control of an aggregate of 5,159,000 common shares (the “Subject Shares”) of infinitii ai inc. (the “Company” or “infinitii”)...
Moody's Ratings assigns ratings to three classes of CLO refinancing no...
Moody's Ratings (Moody's) has assigned ratings to three classes of CLO refinancing notes (the "Refinancing Notes") issued by Generate CLO 5 Ltd. (the "Issuer"). Moody's rating action is as follows: U.S.$3,200,000 Class X-R Floating Rate Notes due 2037, Assigned Aaa (sf) U.S.$288,000,000 Class ...
Moody's Ratings changes Aramark's outlook to positive from stable; aff...
Moody's Ratings (Moody's) affirmed Aramark Services, Inc.'s ("Aramark") corporate family rating ("CFR") at Ba3, probability of default rating at Ba3-PD, and senior secured rating at Ba2. The senior unsecured rating was downgraded to B2 from B1. The Speculative Grade Liquidity ("SGL") rating was down...
Moody's Ratings revises outlook to positive for Advocate Health, Inc. ...
Moody's Ratings (Moody's) has revised the outlook to positive from stable for Advocate Aurora Health (WI), Atrium Health (legally known as Charlotte Mecklenburg Hospital Authority) (NC), and Wake Forest Baptist (NC), and affirmed the Aa3 ratings for Advocate Aurora Health and Atrium Health, and upgr...
Moody's Ratings assigns ratings to two classes of notes issued by Neub...
Moody's Ratings (Moody's) has assigned ratings to two classes of notes issued by Neuberger Berman Loan Advisers LaSalle Street Lending CLO II, Ltd. (the "Issuer" or "Neuberger Berman Loan Advisers LaSalle Street Lending CLO II"). Moody's rating action is as follows: U.S.$240,000,000 Class A-1 Se...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.